United Kingdom · Biopharma startup
United Kingdom · Autolus
Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.
Funding reportedLast round: Post-IPO Equity
Follow Autolus and see its new rounds in your feed.Start following
What company datasets say Autolus raised
Funding, as reported
Reported in all350Min the source's currency
Last roundPost-IPO Equity
Investors listed5
On a portfolio page
Investors who name them
Each firm lists Autolus on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Autolus in front of investors. Or tell us what we have wrong.